School of Medicine

Eduardo Rosa-Molinar has been named the new scientific director of the Washington University Center for Cellular Imaging and has joined the faculty of the Department of Cell Biology & Physiology and the Department of Neuroscience at the School of Medicine.

School of Medicine researchers have shown how brain tumors evolve in response to therapy, helping describe how such cancers develop treatment resistance that leads to the high mortality rate characteristic of this cancer.

David Pagliarini, at Washington University School of Medicine in St. Louis, has been named a Howard Hughes Medical Institute Investigator. He will receive approximately $11 million in funding over seven years in support of research on mitochondria.

Nathan O. Stitziel, MD, PhD, a professor of medicine and of genetics at Washington University School of Medicine in St. Louis, has received the American Heart Association’s Mid-Career Award in Genomic and Precision Medicine.

Washington University School of Medicine scientist Hadas Nahman-Averbuch has received two grants totaling $6 million to investigate the risk factors for developing migraine headaches in adolescents.

Mohamed A. Zayed, MD, PhD, a vascular surgeon known for his pioneering research in vascular diseases, has been appointed director of the newly established Division of Surgical Sciences in the Department of Surgery at Washington University School of Medicine in St. Louis.

The winners of the Big Ideas Competition, which supports novel projects in informatics and health-care delivery, have been announced. The competition is jointly sponsored by the Institute for Informatics, Data Science and Biostatistics at Washington University School of Medicine in St. Louis and the BJC Healthcare Innovation Lab.  

Two studies from Washington University School of Medicine in St. Louis focused on breast cancer and pancreatic cancer suggest that specific types of senescent cells — cells that have stopped dividing and drive inflammation — may play important roles in suppressing the immune system and allowing such tumors to grow unchecked.

The risk of developing long COVID has decreased significantly over the course of the COVID-19 pandemic, primarily due to vaccination, according to a new analysis led by School of Medicine researchers.

A School of Medicine brain-imaging study on the effects of psilocybin, the active compound in magic mushrooms, provides a neurobiological explanation for the drug’s mind-bending effects.